3β,5α-ergostan-3-ol;
General Information
Mainterm | 3β,5α-ergostan-3-ol; |
CAS Reg.No.(or other ID) | 474-60-2 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 119394 |
IUPAC Name | (3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol |
InChI | InChI=1S/C28H50O/c1-18(2)19(3)7-8-20(4)24-11-12-25-23-10-9-21-17-22(29)13-15-27(21,5)26(23)14-16-28(24,25)6/h18-26,29H,7-17H2,1-6H3/t19-,20-,21+,22+,23+,24-,25+,26+,27+,28-/m1/s1 |
InChI Key | ARYTXMNEANMLMU-ATEDBJNTSA-N |
Canonical SMILES | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C |
Molecular Formula | C28H50O |
Wikipedia | campestanol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 402.707 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 5 |
Complexity | 569.0 |
CACTVS Substructure Key Fingerprint | A A A D c f B 4 I A A A A A A A A A A A A A A A A A A A A Y A A A A A w Y M A A A A A A A G D A A A A A G g A A C A A A D x S g g A I C A A A A A g A A A A A A A A A A A A A A A A A A A A A A A A A A E A I A A A A A Q A A E A A A A A A G A w P A P g A A A A A A A A A D A A A Y A A C A A A Q A A C A A A A A = = |
Topological Polar Surface Area | 20.2 |
Monoisotopic Mass | 402.386 |
Exact Mass | 402.386 |
XLogP3 | None |
XLogP3-AA | 9.6 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 29 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9876 |
Human Intestinal Absorption | HIA+ | 0.9972 |
Caco-2 Permeability | Caco2+ | 0.8215 |
P-glycoprotein Substrate | Substrate | 0.6029 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.5251 |
Inhibitor | 0.5425 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7926 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4739 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7510 |
CYP450 2D6 Substrate | Non-substrate | 0.8756 |
CYP450 3A4 Substrate | Substrate | 0.7423 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7578 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7690 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9708 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8526 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9020 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8376 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8855 |
Non-inhibitor | 0.6000 | |
AMES Toxicity | Non AMES toxic | 0.8368 |
Carcinogens | Non-carcinogens | 0.8914 |
Fish Toxicity | High FHMT | 0.9872 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9897 |
Honey Bee Toxicity | High HBT | 0.8091 |
Biodegradation | Not ready biodegradable | 0.9959 |
Acute Oral Toxicity | III | 0.8331 |
Carcinogenicity (Three-class) | Non-required | 0.6887 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.5478 | LogS |
Caco-2 Permeability | 1.4377 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.3821 | LD50, mol/kg |
Fish Toxicity | 0.5342 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.4253 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Steroids and steroid derivatives |
Subclass | Ergostane steroids |
Intermediate Tree Nodes | Not available |
Direct Parent | Ergosterols and derivatives |
Alternative Parents | |
Molecular Framework | Aliphatic homopolycyclic compounds |
Substituents | Ergosterol-skeleton - 3-beta-hydroxysteroid - Hydroxysteroid - 3-hydroxysteroid - Cyclic alcohol - Secondary alcohol - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Alcohol - Aliphatic homopolycyclic compound |
Description | This compound belongs to the class of organic compounds known as ergosterols and derivatives. These are steroids containing ergosta-5,7,22-trien-3beta-ol or a derivative thereof, which is based on the 3beta-hydroxylated ergostane skeleton. |
From ClassyFire